GHCL Launches “Rekoop” Featuring Applied DNA’s CertainT Platform for the First Line of Source-Verified Recycled Plastic Bedding Products

Rekoop Debuts at New York Home Fashions Week, March 19-22

STONY BROOK N.Y.–(BUSINESS WIRE)–Applied
DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ:APDN) today
announced its CertainT®
platform, ensuring authenticity through the entire supply chain, is
featured in global manufacturer of home textiles GHCL,
Limited’s (listed on NSE and BSE) new brand of bedding products made
from recycled plastic (rPET), Rekoop.
It is the first bedding line to feature 100 percent source verified
plastic and will debut at New York Home Fashions Week, March 19 to 22,
2018. The Rekoop bedding products will be manufactured for the US
market and are anticipated toward the end of 2018.

Rekoop employs Applied DNA’s CertainT platform to trace and
authenticate the plastic being utilized in the line of bed sheets,
pillowcases, and shams sold in-store or online in the United States. Reliance
Industries Ltd. (RIL), India’s largest private company, the selected
fiber-manufacturing partner, is using ecofriendly Recon®
Green Gold fiber.

“We are proud to introduce Rekoop, the first fully
source-verified recycled PET bedding product line,” said Manu Kapur,
president and CEO of GHCL Home Textiles. “Applied DNA’s CertainT
platform provides customers and brands with the highest level of trust
in terms of the authenticity of their products.”

“Rekoop bedding highlights the interest brands have in offering
consumers a verifiable guarantee,” said Dr. James A. Hayward, president
and CEO of Applied DNA. “CertainT does what no other system can do – we
can tag every single fiber and verify them through a defined and secure
supply chain through systematic sampling, testing and tracking. Momentum
with retailers and manufacturers across a variety of textiles is growing
and we are pleased to see the CertainT platform and trademark now making
its way onto retail shelves this year,” he added.

Operating its home textiles facility in Vapi, in the state of Gujarat,
India, GHCL has integrated the new CertainT verified rPET fiber into its
production process, from spinning to weaving to finished processed
fabric. One of the leading manufacturers in home textiles in India, the
plant boasts an annual production capacity of 36 million meters of
finished fabric per annum. For more information, please visit www.rekoop.pet.

About GHCL

GHCL is a well-diversified group with footprints in Chemicals, Textiles
and Consumer Products segment. GHCL’s Textiles division is a vertically
integrated manufacturing facility with spinning, wider-width weaving,
continuous fabric processing, and cut & sew facilities for manufacturing
premium quality bed linen. GHCL is one of India’s leading manufacturers
of Home Textiles, with in-house spinning unit having capability to
manufacture multiple varieties of 100% cotton and blended yarns at
various facilities.

GHCL is known as perennial innovators in bed linen category with some of
recent innovations in the category of ‘sheets’ which include the PERFECT
FIT, EASYSHEET, microTWILL, CELLIANT, EXL Wrinkle Free Sheets,
VERSATILE–Reversible Sheets, Soft Wash Percale and Sustainable Fibre
dyed sheets.

GHCL’s Home Textiles products are predominantly exported worldwide to
countries like United Kingdom, United States of America, Australia,
Canada, Germany and other European Union countries as well.

About Reliance Industries

Reliance Industries (RIL) is India’s largest private sector company,
with a consolidated turnover of INR 330,180 crore ($ 50.9 billion), cash
profit of INR 42,800 crore ($ 6.6 billion), and net profit of INR 29,901
crore ($ 4.6 billion) for the year ended March 31, 2017. RIL is the
first private sector company from India to feature in Fortune’s Global
500 list of ‘World’s Largest Corporations’ – currently ranking 203rd in
terms of revenues, and 110th in terms of profits. The company stands
106th in the ‘Forbes Global 2000’ rankings for 2017 – the top-most among
Indian companies. It ranks 10th in LinkedIn’s ‘Top Companies Where India
Wants to Work Now’ (2017). RIL’s activities span hydrocarbon exploration
and production, petroleum refining and marketing, petrochemicals, retail
and 4G digital services.

About Applied DNA Sciences

Applied DNA is a provider of molecular technologies that enable supply
chain security, anti-counterfeiting and anti-theft technology, product
genotyping and DNA mass production for diagnostics and therapeutics.

Applied DNA makes life real and safe by providing innovative,
molecular-based technology solutions and services that can help protect
products, brands, entire supply chains, and intellectual property of
companies, governments and consumers from theft, counterfeiting, fraud
and diversion. The proprietary DNA-molecular based “CertainT®”
platform can be used to identify, tag, test, and track products, to help
assure authenticity, origin, traceability, sustainability and quality of
products. SigNature® DNA describes the core technology
ingredient that is at the heart of a family of uncopyable, security and
authentication solutions such as SigNature® T and fiberTyping®,
targeted toward textiles and apparel, BackTrac™ and DNAnet®,
for anti-theft and loss prevention, and digitalDNA®,
providing powerful track-and-trace. All provide a forensic chain of
evidence, and can be used to prosecute perpetrators. Applied DNA
Sciences is also engaged in the large-scale production of specific DNA
sequences using the polymerase chain reaction.

Visit adnas.com for
more information. Follow us on Twitter and LinkedIn.
Join our mailing
list.

Common stock listed on NASDAQ under the symbol APDN, and warrants are
listed under the symbol APDNW.

Forward Looking Statements

The statements made by Applied DNA in this press release may be
“forward-looking” in nature within the meaning of the Private Securities
Litigation Act of 1995. Forward-looking statements describe Applied
DNA’s future plans, projections, strategies and expectations, and are
based on assumptions and involve a number of risks and uncertainties,
many of which are beyond the control of Applied DNA. Actual results
could differ materially from those projected due to our lack of
significant revenues, limited financial resources, limited market
acceptance, history of net losses, market competition and various other
factors detailed from time to time in Applied DNA’s SEC reports and
filings, including our Annual Report on Form 10-K filed on December 28,
2017 and our subsequent quarterly report on Form 10-Q filed on February
8, 2018, which are available at www.sec.gov.
Applied DNA undertakes no obligation to update publicly any
forward-looking statements to reflect new information, events or
circumstances after the date hereof to reflect the occurrence of
unanticipated events, unless otherwise required by law.

Contacts

Applied DNA Sciences, Inc.
investors:
Sanjay Hurry,
212-838-3777
[email protected]
or
media:
Angie
Mathews, 781-639-4924
[email protected]
or
program:
MeiLin
Wan, 631-240-8849
[email protected]
or
Deepika Abrol,
0120 3358180
[email protected]
or
web: www.adnas.com
twitter:
@APDN